LEADER WOMENS LAXATIVE- bisacodyl tablet, coated 
Cardinal Health

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Cardinal Health Women's Laxative Drug Facts

Active ingredient (in each tablet)

Bisacodyl USP 5 mg

Purpose

Laxative

Uses

for relief of occasional constipation and irregularity

Warnings

Ask a doctor before use if you have

abdominal pain
nausea
vomiting
a sudden change in bowel habits that persists over a period of 2 weeks

When using this product

you may experience stomach discomfort, faintness, and cramps may occur
Swallow tablets whole, do not chew or crush
do not use within 1 hour after taking an antacid or milk
expect results in 6-12 hours

Stop use and ask a doctor if

you fail to have a bowel movement after use
rectal bleeding occurs
you need to use a laxative for more than one week

If pregnant or breast-feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center Immediately.

Directions

adults and children 12 years of age and over

take 1 to 3 tablets in a single dose once daily

children 6 to under 12 years of age

take 1 tablet in a single dose once daily

children under 6 years of age

ask a doctor

Other information

do not use if individual blister compartments are broken or open
Store at room temperature
Protect from moisture
Retain carton for complete information

Inactive ingredients

acacia, calcium sulfate anhydrous, carnauba wax, colloidal silicon dioxide, corn starch, D&C red #7 calcium lake, hypromellose phthalate, Iron oxide, Iron oxide black, Iron oxide yellow, kaolin, magnesium stearate, microcrystalline cellulose, polyethylene glycol (PEG) 400, povidone, shellac, sodium starch glycolate, stearic acid, sugar, talc, titanium dioxide, triacetin.

Questions or comments?

1-800-719-9260

Principal Display Panel

Compare to Correctol® Tablets active ingredient

Women’s Laxative

Bisacodyl USP 5 mg

For Gentle, Dependable Overnight Relief

For Gentle, Overnight Relief from Irregularity

SATISFACTION GUARANTEED

30 COATED TABLETS

Distributed By:

Cardinal Health

Dublin, Ohio 43017

www.myleader.com

CIN 2712586

Woman Laxative 30 Coated Tablets

Women's Laxative Carton

LEADER WOMENS LAXATIVE 
bisacodyl tablet, coated
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:37205-298
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
BISACODYL (UNII: 10X0709Y6I) (DEACETYLBISACODYL - UNII:R09078E41Y) BISACODYL5 mg
Inactive Ingredients
Ingredient NameStrength
ACACIA (UNII: 5C5403N26O)  
CALCIUM SULFATE ANHYDROUS (UNII: E934B3V59H)  
CARNAUBA WAX (UNII: R12CBM0EIZ)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
STARCH, CORN (UNII: O8232NY3SJ)  
D&C RED NO. 7 (UNII: ECW0LZ41X8)  
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO)  
FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
KAOLIN (UNII: 24H4NWX5CO)  
MAGNESIUM STEARATE (UNII: 70097M6I30)  
MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)  
POVIDONE, UNSPECIFIED (UNII: FZ989GH94E)  
SHELLAC (UNII: 46N107B71O)  
SODIUM STARCH GLYCOLATE TYPE A POTATO (UNII: 5856J3G2A2)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
RAW SUGAR (UNII: 8M707QY5GH)  
TALC (UNII: 7SEV7J4R1U)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
TRIACETIN (UNII: XHX3C3X673)  
Product Characteristics
ColorPINK (polished) Scoreno score
ShapeROUNDSize10mm
FlavorImprint Code 174
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:37205-298-652 in 1 CARTON08/16/2019
115 in 1 BLISTER PACK; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart33408/16/2019
Labeler - Cardinal Health (097537435)

Revised: 1/2021
Document Id: 84df6b11-fe2a-4329-ac6f-152deb04d10e
Set id: 70d6039d-a379-410d-984a-9ff8cfa599c5
Version: 4
Effective Time: 20210122
 
Cardinal Health